AstraZeneca PLC is 214.6x more valuable than SELLAS Life Sciences Group, Inc. by market capitalization ($286.27 B vs $1.33 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | SLS | AZN |
|---|---|---|
| Market cap | $1.33 B | $286.27 B |
| US-listed rank | #2422 | #45 |
| Revenue (latest FY) | $0.00 | - |
| Net income (latest FY) | -$26.86M | - |
| SEC filings | 1,262 | 1,004 |
AstraZeneca PLC is 214.6x more valuable than SELLAS Life Sciences Group, Inc. by market capitalization ($286.27 B vs $1.33 B).
Full pages: SELLAS Life Sciences Group, Inc. and AstraZeneca PLC, or browse the full rankings.